Cognat, Emmanuel
Inserm · Université Paris Cité
7 papers on CoChatORCID 0000-0002-3521-5832
Most cited papers
- Verified
Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum.
Benedet, A. L., Milà-Alomà, M., Vrillon, A., Ashton, N. J., Pascoal, T. A., Lussier, F., Karikari, T. K., Hourregue, C., Cognat, E., Dumurgier, J., et al. (2021) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 638
- Verified · note
CADASIL and CARASIL
Tikka, S., Baumann, M., Siitonen, M., Pasanen, P., Pöyhönen, M., Myllykangas, L., Viitanen, M., Fukutake, T., Cognat, E., Joutel, A., et al. (2014) · Brain Pathology
Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments
Cited by 189
- Verified
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability
Therriault, J., Janelidze, S., Benedet, A. L., Ashton, N. J., Arranz Martínez, J., Gonzalez-Escalante, A., Bellaver, B., Alcolea, D., Vrillon, A., Karim, H., et al. (2024) · Nature Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 131
- Verified
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
Boza-Serrano, A., Vrillon, A., Minta, K., Paulus, A., Camprubí-Ferrer, L., Garcia, M., Andreasson, U., Antonell, A., Wennström, M., Gouras, G., et al. (2022) · Acta Neuropathologica
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 66
- Verified
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study
Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024) · Journal of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 28
- Verified
Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients
Lilamand, M., Bouaziz-Amar, E., Dumurgier, J., Cognat, E., Hourregue, C., Mouton-Liger, F., Sanchez, M., Troussière, A.-C., Martinet, M., Hugon, J., et al. (2023) · The Journals of Gerontology: Series A
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 27
- Verified
Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia
Marelli, C., Hourregue, C., Gutierrez, L.-A., Paquet, C., Menjot de Champfleur, N., De Verbizier, D., Jacob, M., Dubois, J., Maleska, A. M., Hirtz, C., et al. (2020) · Journal of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free